It is a pharma private limited company based in Katraj Pune, Maharashtra, India, established in 2018.
2018 | Katraj Pune, Maharashtra, India | ActiveEdallia Pharmaceuticals Private Limited, a active private limited company, was established on 12 April 2018 in Katraj Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999PN2018PTC175988. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shubhangi Parmale (Director), Amol Ashok Parmale (Director). Past directors included Pradnya Dinesh Inamdar, Rohit Vishnu Joshi, Amol Ashok Parmale. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S No 22 Prime Heritage F No 5 Mahavir Nagar Near Datta Mandir Sukhsagar Nagar, Katraj Pune, Maharashtra, 411046.
U74999PN2018PTC175988
175988
12 April 2018
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Edallia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shubhangi Parmale | Director | 12 Apr 2018 | Current |
| Amol Ashok Parmale | Director | 31 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2019 | Past |
| Pramod Abcsdd | Director | 31 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Edallia Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.95% increase. The company also saw a substantial improvement in profitability, with a 262.81% increase in profit. The company's net worth Soared by an impressive increase of 57.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Edallia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Edallia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Edallia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edallia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Edallia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Edallia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Amol Ashok Parmale was appointed as a Director was appointed as a Director on 31 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
The activity Shubhangi Parmale was appointed as a Director was appointed as a Director on 12 Apr 2018 & has been associated with this company since 7 years 8 months . was completed.
Edallia Pharmaceuticals Private Limited was registered on 12 Apr 2018 with Roc Pune & aged 7 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Edallia Pharmaceuticals Private Limited is U74999PN2018PTC175988.
Edallia Pharmaceuticals Private Limited is headquartered at S No 22 Prime Heritage F No 5 Mahavir Nagar Near Datta Mandir Sukhsagar Nagar, Katraj Pune, Maharashtra, 411046.
Edallia Pharmaceuticals Private Limited was incorporated on 12 April 2018.
The current directors of Edallia Pharmaceuticals Private Limited are
The primary industry of Edallia Pharmaceuticals Private Limited is Trade.
Edallia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Edallia Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX